Authors:
JAMES LP
MAROTTI T
STOWE C
FARRAR H
TAYLOR B
KEARNS GL
Citation: Lp. James et al., FAMOTIDINE PHARMACOKINETICS AND PHARMACODYNAMICS IN INFANTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 72-72
Authors:
GOTSCHALL R
LEEDER JS
FARRAR H
MCCUBBIN M
JOHNSON K
KEARNS GL
Citation: R. Gotschall et al., CAFFEINE PLASMA-CLEARANCE IN CYSTIC-FIBROSIS (CF) DOES NOT CORRELATE WITH CYP1A2 ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 79-79
Citation: H. Farrar et al., MIDAZOLAM DISPOSITION IN PEDIATRIC-PATIENTS - A PILOT-STUDY AS A CYP3A4 PROBE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 64-64
Authors:
JAMES L
SCHEXNAYDER S
FARRAR H
WELLS T
KEARNS G
Citation: L. James et al., CONTINUOUS-INFUSION PRALIDOXIME IN THE TREATMENT OF ORGANOPHOSPHATE INTOXICATION - PHARMACOKINETICS IN CHILDREN, Clinical pharmacology and therapeutics, 61(2), 1997, p.
Citation: H. Farrar et al., ADVANCEMENTS IN INTERNATIONALLY ACCEPTED STANDARDS FOR RADIATION PROCESSING, Radiation physics and chemistry, 42(4-6), 1993, pp. 853-856